• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL EU ENT4.5MMD 28MML WNO DSTL TP; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL EU ENT4.5MMD 28MML WNO DSTL TP; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Model Number 641CX0202
Medical Device Problem Code Activation Failure (3270)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/03/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).This complaint is from a literature source.The citation is as follows: zhang k, xia jc, gao hl, gao bl, wang yf, li zs, li tx, wang zl.Case report: double micro-guidewire technique for emergent rescue of proximal stent collapse during recanalization of nonacute occlusion of vertebral artery.Front neurol.2021 sep 3;12:671158.Doi: 10.3389/fneur.2021.671158.Pmid: 34539544; pmcid: pmc8446545.The expiration date of the device is not known as the device lot number is not available / not reported.The initial reporter phone is not available / reported.The device manufacture date is not known as the device lot number is not available / not reported.Due to the nature of the complaint, the device (s) were not returned for analysis nor was the sterile lot numbers provided in order to conduct a lot history review.As a result, we are closing this investigation.If the complaint device is received in the future, we will reopen the complaint and perform the investigation as appropriate.The enterprise vascular reconstruction device (vrd) is intended for use with occlusive devices in the treatment of intracranial aneurysms.It is not intended for use as a stand-alone device, i.E., without subsequent coil embolization of the aneurysm.This stent was used off-label for the treatment of a v4 segment occlusion of the right vertebral artery.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event or Problem Description
This complaint is from a literature source.The citation is as follows: zhang k, xia jc, gao hl, gao bl, wang yf, li zs, li tx, wang zl.Case report: double micro-guidewire technique for emergent rescue of proximal stent collapse during recanalization of nonacute occlusion of vertebral artery.Front neurol.2021 sep 3;12:671158.Doi: 10.3389/fneur.2021.671158.Pmid: 34539544; pmcid: pmc8446545.Objective and methods: the article reports a case with v4 segment occlusion of the right vertebral artery treated with endovascular stent angioplasty.Lot number is not available, but the suspected cerenovus device possibly associated with reported event: 4.5mm x 28mm enterprise stent.Other cerenovus devices that were also used in this study: n/a.Non-cerenovus devices that were also used in this study: 2.0 × 13 mm gateway balloon (stryker), 300-cm traxcess micro-guidewire (0.014 inch, medtronic), echelon 10 microcatheter (medtronic).Adverse event(s) and provided interventions: a male patient in his 50s underwent endovascular stent angioplasty of a v4 segment occlusion with a 4.5mm x 28mm enterprise stent.The enterprise stent deployed at the occlusion segment was collapsed at the proximal end after withdrawal of the delivery system.Immediate rescuing measures were taken by navigating a micro-guidewire through the lateral stent mesh at the proximal end into the stent lumen followed by advancing a second micro-guidewire right through the reopened proximal stent end into the stent lumen for deployment of a supporting balloon-expandable apollo stent to prevent stent collapse.After stenting, both stents were well-patent with favorable forward flow.Follow-up digital subtraction angiography 6 months later demonstrated patent stents and unobstructed blood flow.
 
Event or Problem Description
This complaint is from a literature source.The citation is as follows: zhang k, xia jc, gao hl, gao bl, wang yf, li zs, li tx, wang zl.Case report: double micro-guidewire technique for emergent rescue of proximal stent collapse during recanalization of nonacute occlusion of vertebral artery.Front neurol.2021 sep 3;12:671158.Doi: 10.3389/fneur.2021.671158.Pmid: 34539544; pmcid: pmc8446545.Objective and methods: the article reports a case with v4 segment occlusion of the right vertebral artery treated with endovascular stent angioplasty.Lot number is not available, but the suspected cerenovus device possibly associated with reported event: 4.5mm x 28mm enterprise stent.Other cerenovus devices that were also used in this study: n/a.Non-cerenovus devices that were also used in this study: 2.0 × 13 mm gateway balloon (stryker), 300-cm traxcess micro-guidewire (0.014 inch, medtronic), echelon 10 microcatheter (medtronic).Adverse event(s) and provided interventions: a male patient in his 50s underwent endovascular stent angioplasty of a v4 segment occlusion with a 4.5mm x 28mm enterprise stent.The enterprise stent deployed at the occlusion segment was collapsed at the proximal end after withdrawal of the delivery system.Immediate rescuing measures were taken by navigating a micro-guidewire through the lateral stent mesh at the proximal end into the stent lumen followed by advancing a second micro-guidewire right through the reopened proximal stent end into the stent lumen for deployment of a supporting balloon-expandable apollo stent to prevent stent collapse.After stenting, both stents were well-patent with favorable forward flow.Follow-up digital subtraction angiography 6 months later demonstrated patent stents and unobstructed blood flow.
 
Additional Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).This complaint is from a literature source.The citation is as follows: zhang k, xia jc, gao hl, gao bl, wang yf, li zs, li tx, wang zl.Case report: double micro-guidewire technique for emergent rescue of proximal stent collapse during recanalization of nonacute occlusion of vertebral artery.Front neurol.2021 sep 3;12:671158.Doi: 10.3389/fneur.2021.671158.Pmid: 34539544; pmcid: pmc8446545.The expiration date of the device is not known as the device lot number is not available / not reported.The initial reporter phone is not available / reported.The device manufacture date is not known as the device lot number is not available / not reported.Due to the nature of the complaint, the device (s) were not returned for analysis nor was the sterile lot numbers provided in order to conduct a lot history review.As a result, we are closing this investigation.If the complaint device is received in the future, we will reopen the complaint and perform the investigation as appropriate.The enterprise vascular reconstruction device (vrd) is intended for use with occlusive devices in the treatment of intracranial aneurysms.It is not intended for use as a stand-alone device, i.E., without subsequent coil embolization of the aneurysm.This stent was used off-label for the treatment of a v4 segment occlusion of the right vertebral artery.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Additional Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to add the non-cerenovus devices that were also used in this study: 2.0 × 13 mm gateway balloon (stryker), 300-cm traxcess micro-guidewire (0.014 inch, medtronic), echelon 10 microcatheter (medtronic) updated sections: b.4, g.3, g.6, h.2, h.10, and concomitant products.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EU ENT4.5MMD 28MML WNO DSTL TP
Common Device Name
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
gabriel alfageme
31 technology dr
irvine, CA 92618
949789-8687
MDR Report Key13012344
Report Number3008114965-2021-00678
Device Sequence Number17374954
Product Code NJE
UDI-Device Identifier10878528008894
UDI-Public10878528008894
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
H60001
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Literature,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number641CX0202
Device Catalogue NumberENC452800
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/15/2021
Supplement Date Received by Manufacturer12/15/2021
Initial Report FDA Received Date12/15/2021
Supplement Report FDA Received Date12/15/2021
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
2.0 × 13 MM GATEWAY BALLOON (STRYKER); 300CM TRAXCESS MICROGUIDEWIRE (MICROVENTION); ECHELON 10 MICROCATHETER (MEDTRONIC)
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-